Docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer

  • Technology appraisal guidance
  • TA26
  • Published: 

This guidance has been replaced by NICE guideline CG24 [Replaced by NICE guideline CG121].